C3 and systemic lupus erythematosus: A third of all patients in this otherwise representative SLE cohort never demonstrated evidence of hypocomplementemia, which is in line with a reported range of 30-50% patients maintaining normal C3 and C4 levels throughout their disease [9, 28–30].